Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

CLOROX CO (CLX)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:26pm CET

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX CO
11/16 CLOROX CO /DE/ : Submission of Matters to a Vote of Security Holders (form 8-K)
11/14 CLOROX : Declares Regular Quarterly Dividend of 84 Cents Per Share
11/13 CLOROX : Kingsford employees not pleased with proposed schedule
11/10 CLOROX : Earns 100 Percent Score on Human Rights Campaign Foundation Annual Scor..
11/09 CLOROX : Kingsford Charcoal, Walmart Recognize Nearly 60 Years of Manufacturing ..
11/02 CLOROX : Wipe Out The Flu Before It Wipes Out Your Plans
11/01 CLOROX CO /DE/ : Change in Directors or Principal Officers (form 8-K)
11/01 CLOROX : DE/ Management's Discussion and Analysis of Financial Condition and Res..
11/01 CLOROX COMPANY (THE) (NYSE : CLX) reported earnings of $1.46 per share beating W..
11/01 CLOROX CO /DE/ : Results of Operations and Financial Condition (form 8-K)
More news
News from SeekingAlpha
04:50a Dividend Champions To Buy, Sell, And Hold - Part 3
11/20 THE IM-CAPITAL STRENGTH 20-STOCK UNI : Update November 2017
11/17 CLOROX : Return On Equity Over 100%
11/14 Clorox declares $0.84 dividend
11/11 Stocks to watch next week
Financials ($)
Sales 2018 6 133 M
EBIT 2018 1 163 M
Net income 2018 737 M
Debt 2018 1 693 M
Yield 2018 2,52%
P/E ratio 2018 23,98
P/E ratio 2019 22,35
EV / Sales 2018 3,11x
EV / Sales 2019 3,02x
Capitalization 17 400 M
Chart CLOROX CO
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 133 $
Spread / Average Target -1,6%
EPS Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Dawn C. Willoughby Chief Operating Officer & Executive VP
Stephen M. Robb Chief Financial Officer & Executive Vice President
James E. Foster EVP-Product Supply, Enterprise Performance & IT
Manjit Singh Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO12.61%17 400
UNILEVER INDONESIA TBK PT--.--%27 920
CHURCH & DWIGHT CO., INC.1.29%11 187
LION CORP3.18%5 315
KOBAYASHI PHARMACEUTICAL CO LTD37.33%5 074
WD-40 COMPANY-2.31%1 595